What Is the Correct Pinealon Dosage?
The most commonly reported pinealon dosage in clinical practice is 0.1–0.3 mg per administration, given via subcutaneous injection, typically over a short cycle of 5–10 days repeated periodically. However, there is no FDA-approved dosage and clinical evidence in humans is limited.
Pinealon Dosage Overview
| Parameter | Typical Protocol |
|---|---|
| Dose per injection | 0.1–0.3 mg (100–300 mcg) |
| Route | Subcutaneous injection (most common); intranasal (less common) |
| Frequency | Once daily |
| Cycle length | 5–10 days |
| Cycle frequency | 1–2 times per year (common approach) |
| Storage | Refrigerate after reconstitution; use within 30 days |
Is Pinealon FDA Approved?
No. Pinealon is not FDA approved for any medical indication. It is a peptide bioregulator developed in Russia (originally by the St. Petersburg Institute of Bioregulation and Gerontology) and used clinically in Eastern Europe and Russia, but it has not gone through the US FDA approval process.
In the United States, Pinealon is not commercially available through standard pharmaceutical channels. It may be obtained through:
- Specialty import (legal status is a gray area under FDA enforcement discretion)
- Some international compounding pharmacies
It is not prescribable at licensed US compounding pharmacies because it is not on the FDA's bulk substances list.
Pinealon Administration Methods
Subcutaneous Injection (Most Common)
Pinealon is most commonly reconstituted from lyophilized powder with bacteriostatic water and injected subcutaneously (under the skin), typically in the abdomen or thigh. Use a 27–31 gauge insulin syringe.
Reconstitution: Add 1–2 mL of bacteriostatic water to the lyophilized vial. A 20 mg vial with 2 mL BAC water gives 10 mg/mL concentration.
Intranasal / Sublingual
Some protocols describe intranasal or sublingual administration. These routes have lower bioavailability than injection but are reported by some users as more convenient. Specific dosing adjustments for these routes are not well established.
Pinealon Dosage by Intended Use
Cognitive / Neuroprotective
Most research on Pinealon relates to neuroprotection, with animal studies suggesting benefits for age-related cognitive decline and retinal cell protection. The typical protocol in Eastern European clinical use for cognitive support is:
- 0.1–0.2 mg subcutaneous daily for 5–10 days
- Repeated once or twice annually
Anti-Aging / Longevity
Some providers include Pinealon in broader peptide bioregulator "longevity stacks." In this context it is often combined with Epithalon, Thymogen, or other bioregulators at similar doses.
Pinealon + Glycine: What Is the Combination?
Pinealon is a tripeptide composed of the amino acids Glu-Asp-Arg. Some formulations or research protocols pair Pinealon with glycine, which is also considered neuroprotective. The combination is sometimes sold together by research suppliers. Standard Pinealon protocols do not require glycine supplementation, but the combination is not harmful at typical supplemental glycine doses.
Pinealon Safety Considerations
- Human safety data is limited and comes primarily from Russian clinical registry studies, not Western randomized controlled trials
- Animal studies suggest good tolerability with no significant adverse effects at standard doses
- Injection site reactions (mild redness, swelling) are the most commonly reported issue
- Because Pinealon is not subject to FDA manufacturing oversight when obtained from overseas, product quality cannot be guaranteed
Frequently Asked Questions
What is the recommended pinealon dosage?
The most commonly cited clinical dose is 0.1–0.3 mg per day via subcutaneous injection over a 5–10 day cycle. This is not an FDA-established dose — it comes from Eastern European clinical use patterns and research.
Is pinealon FDA approved?
No. Pinealon is not FDA approved and is not legally available through licensed US compounding pharmacies. Patients obtaining it from overseas research suppliers should understand the regulatory and quality risks.
How often do you take pinealon?
Most protocols describe short cycles (5–10 days) rather than daily chronic administration. Cycles are typically repeated 1–2 times per year.
What does pinealon do?
Pinealon is a peptide bioregulator thought to support pineal gland function and neuroprotection. Animal research suggests benefits for retinal cells and age-related cognitive decline. Human evidence is limited to Russian clinical studies.
Can pinealon be taken orally?
Oral bioavailability for peptides is generally low due to digestive enzymes breaking them down. Sublingual and intranasal routes are sometimes used as alternatives to injection, but efficacy data for these routes is limited.
This content is for informational purposes only. Pinealon has no FDA approval and human evidence is limited. Do not start any peptide protocol without consulting a qualified healthcare provider.
